Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-12-09Clinical Trial Update: The Use of Resting State, fMRI and DTI in the Identification of Chronic Pain Conditions
Brain Scan Inc. is conducting a trial to identify chronic pain conditions using resting-state fMRI and diffusion tensor imaging (DTI). The c…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: the Effect of Spray on Propofol Injection Pain [Phase 4]
Phase 4 clinical trial update evaluating whether a spray reduces pain from propofol injections; the study is completed.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: 40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose [Phase 4]
Phase 4 trial shows that 40% orally administered dextrose gel is more effective than 25% dextrose gel in treating acute pain.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Intranasal Sufentanil Pain-management at Entrance of Emergency Department : Influence on Pain-relief Delay [Phase 4]
Phase 4 clinical trial update on intranasal sufentanil for pain relief at ED entry in adults with severe traumatic limb injuries; the study …
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair [Phase 3]
Phase 3 trial evaluating trigger-point blockade to treat persistent pain after open groin hernia repair has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: ANI and NoL Index Variations After Standard Nociceptive Stimulus at 0, 50, 25 % of Inhaled N2O in the Anesthetic Mixture [Phase 4]
Phase 4 trial update evaluating how ANI and NoL nociception indices vary after nociceptive stimulation with different percentages of inhaled…
-
FDA approval · 2016-11-14FDA Approved: MORPHINE SULFATE — Original Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved Morphine Sulfate as an Original Application generic product (ANDA 206573) for PAI Holdings dba PAI Pharma.
-
FDA approval · 2016-11-04FDA Approved: FENTANYL SYSTEM — Original Application (ALVOGEN)
The FDA has approved ALVOGEN's FENTANYL SYSTEM as an original-application generic product.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV) [Phase 3]
Phase 3 trial evaluating CL-108 for acute pain and opioid-induced nausea and vomiting has completed.
-
FDA approval · 2016-11-02FDA Approved: UP AND UP IBUPROFEN PM — Supplemental Application (Target Corporation)
FDA approved a supplemental application for Target's Up and Up Ibuprofen PM, a diphenhydramine citrate and ibuprofen combination product int…
-
FDA approval · 2016-11-01FDA Approved: KETOROLAC TROMETHAMINE — Original Application (FOSUN PHARMA USA INC)
FDA approved the original application for a generic ketorolac tromethamine product from Fosun Pharma USA Inc, for short-term relief of moder…
-
FDA approval · 2016-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for Methadone Hydrochloride by VistaPharm, LLC, enabling the generic product to be marketed. This ac…
-
FDA approval · 2016-10-28FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride (SpecGx LLC), confirming continued approval and availability of this gen…
-
CLINICAL_TRIALS withdrawal · 2016-10-26Clinical Trial Update: OASIS: Osteoarthritis Sensitivity Integration Study [NA]
The OASIS trial evaluating osteoarthritis sensitivity integration has been withdrawn from the registry. No further development or results ar…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain [Phase 4]
A Phase 4 trial comparing remifentanil to fentanyl during cardiac surgery and for chronic thoracic pain has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Intranasal Ketamine as a Sedative for Venipuncture [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating intranasal ketamine as a sedative for venipuncture has completed.
-
FDA approval · 2016-10-10FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ketorolac tromethamine from Sun Pharmaceutical Industries, Inc. This action confirms regulatory …
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Catastrophism Among Chronic Pain Patients in Rheumatology
A clinical trial investigating catastrophizing pain in chronic pain patients with rheumatic conditions has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Safety and Effectiveness of Spinal Cord Stimulation With Automatic Control to Treat Chronic Pain in an Extended Trial [NA]
This update reports safety and effectiveness findings from an extended trial of Saluda Medical’s spinal cord stimulation with automatic cont…
-
FDA approval · 2016-09-30FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2016-09-30FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for a generic methadone hydrochloride product from VistaPharm, LLC. The drug is used for opioid use …
-
FDA approval · 2016-09-30FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Tapentadol hydrochloride submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2016-09-30FDA Approved: MORPHINE SULFATE EXTENDED RELEASE — Supplemental Application (Rhodes Pharmaceuticals L. P.)
FDA approved a supplemental application for Morphine Sulfate Extended Release from Rhodes Pharmaceuticals L.P., approving changes under a su…
-
FDA approval · 2016-09-30FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for methadone hydrochloride from Aurolife Pharma, LLC, making a generic version of the drug availabl…
-
FDA approval · 2016-09-30FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for methadone hydrochloride from Epic Pharma, LLC.